Core Insights - Zacks Premium offers tools for investors to enhance their stock market strategies, including daily updates on Zacks Rank and Industry Rank, Equity Research reports, and Premium stock screens [1][2] Zacks Style Scores - Zacks Style Scores are indicators that rate stocks based on value, growth, and momentum methodologies, helping investors identify stocks likely to outperform the market in the next 30 days [2] - Stocks are rated from A to F, with A indicating the highest potential for outperformance [3] Value Score - The Value Style Score focuses on identifying undervalued stocks using ratios like P/E, PEG, Price/Sales, and Price/Cash Flow [3] Growth Score - The Growth Style Score evaluates stocks based on projected and historical earnings, sales, and cash flow to find those with sustainable growth potential [4] Momentum Score - The Momentum Style Score identifies optimal times to invest based on price trends and earnings estimate changes [5] VGM Score - The VGM Score combines the three Style Scores to highlight stocks with attractive value, strong growth forecasts, and promising momentum [6] Zacks Rank Integration - The Zacks Rank uses earnings estimate revisions to help investors build successful portfolios, with 1 (Strong Buy) stocks achieving an average annual return of +23.75% since 1988, outperforming the S&P 500 [7] - Investors are encouraged to select stocks with a Zacks Rank of 1 or 2 and Style Scores of A or B for optimal success [9] Company Spotlight: Vertiv Holdings Co. (VRT) - Vertiv is a global provider of critical digital infrastructure and services, serving industries such as cloud computing, financial services, and healthcare [11] - VRT holds a Zacks Rank of 3 (Hold) and a VGM Score of A, indicating potential for growth [11] - The company is projected to achieve year-over-year earnings growth of 30.5% for the current fiscal year, with upward revisions in earnings estimates [12]

Chagee Holdings Limited - Sponsored ADR (CHA) has been on a downward spiral lately with significant selling pressure. After declining 22.2% over the past four weeks, the stock looks well positioned for a trend reversal as it is now in oversold territory and there is strong agreement among Wall Street analysts that the company will report better earnings than they predicted earlier.We use Relative Strength Index (RSI), one of the most commonly used technical indicators, for spotting whether a stock is overso ...

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?Let's take a look at what these Wall Street heavyweights have to say about Viking Therapeutics, Inc. (VKTX) before we discuss the reliability of brokerage recommendations and how to use them to your advantage.Viking Therapeutics curre ...

Core Insights - DENTSPLY SIRONA Inc. is set to release its second-quarter 2025 results on August 7, with expectations of revenue at $851.6 million and earnings at 29 cents per share [2][3] Group 1: Q2 Performance Expectations - The company has shown an average earnings surprise of 2.73% over the past four quarters, indicating a potential for positive performance [2] - The Imaging segment is expected to benefit from the relaunch of Orthophos SL and Primescan 2, which may have driven growth, particularly in Europe and APAC [4] - Orthodontics, particularly SureSmile, is anticipated to show stable global growth, although U.S. performance may be hindered by softer discretionary spending [5] Group 2: Challenges and Headwinds - The suspension of Byte aligner sales is projected to negatively impact organic sales by approximately two percentage points in 2025, affecting second-quarter results as well [6] - Essential Dental Solutions may have experienced stable patient traffic, but overall segment growth is likely to be limited by softness in elective procedures and weak U.S. implant sales [7] - Connected Technology Solutions, including CAD/CAM, continues to face macroeconomic pressures, with subdued retail demand in the U.S. despite growth in Germany [8] Group 3: Operational Insights - DENTSPLY SIRONA's Phase II transformation activities are on track to deliver full run-rate savings by the end of 2025, with expectations of gradual stabilization in gross margins throughout the year [9] - Cost initiatives and SKU rationalization may contribute to improved gross margins, aiding quarter-over-quarter growth in Q2 [11] Group 4: Earnings Prediction Model - The current model does not predict an earnings beat for DENTSPLY SIRONA, with an Earnings ESP of -0.99% and a Zacks Rank of 2 [12][13]

Key Takeaways ZBH is projected to post Q2 revenues of $2.04B, up 5.3% year over year.Zimmer Biomet's Hip and Knee units likely drove growth with new implant systems and ROSA traction.ZBH's S.E.T. business expected to rise 2.6% on the back of Paragon 28 acquisition benefits.Zimmer Biomet Holdings, Inc. (ZBH) is scheduled to report second-quarter 2025 results on Aug. 7, before market open.In the last reported quarter, the company’s earnings of $1.81 surpassed the Zacks Consensus Estimate by 2.84%. ZBH beat on ...

Core Viewpoint - NiSource (NI) is set to release its second-quarter 2025 results on August 6, with an earnings surprise of 8.9% in the previous quarter [1] Factors Impacting Q2 Performance - The second-quarter earnings are expected to benefit from new electric and gas rates effective in the company's service regions [2][8] - The completion of the Dunns Bridge II solar and storage project by Northern Indiana Public Service Company LLC (NIPSCO) is anticipated to positively impact performance [2][8] - Increased investments in infrastructure enhancement and capital programs, along with flat operation and maintenance expenses, are expected to support the bottom line [3][8] - However, higher depreciation and amortization expenses may offset some of these positive factors [3] Q2 Expectations - The Zacks Consensus Estimate for earnings is 21 cents per share, indicating no change from the previous year [4] - The Zacks Consensus Estimate for revenues is $1.15 billion, reflecting a 6.1% increase from the year-ago figure [4] Earnings Prediction Model - The current model does not predict an earnings beat for NiSource, with an Earnings ESP of 0.00% [5] - NiSource holds a Zacks Rank of 2 (Buy) [6] Comparable Stocks - Spire (SR) is expected to report an earnings beat with an Earnings ESP of +14.81% and a Zacks Rank 3 [7] - ONE Gas (OGS) is also likely to report an earnings beat with an Earnings ESP of +3.22% and a Zacks Rank 2 [9] - MDU Resources Group (MDU) is predicted to have an earnings beat with an Earnings ESP of +20% and a Zacks Rank 2 [10]

Company Performance - AeroVironment (AVAV) closed at $260.07, reflecting a -2.83% change from the previous day's closing price, underperforming compared to the S&P 500's 1.6% loss [1] - Over the past month, shares of AeroVironment have increased by 8.7%, outperforming the Aerospace sector's gain of 3.87% and the S&P 500's gain of 2.25% [1] Upcoming Earnings - Analysts expect AeroVironment to report earnings of $0.34 per share, indicating a year-over-year decline of 61.8% [2] - The consensus estimate for revenue is $453.5 million, representing a significant increase of 139.34% from the same quarter last year [2] Full-Year Estimates - The Zacks Consensus Estimates for AeroVironment's full-year earnings are projected at $3.23 per share, reflecting a year-over-year decline of 1.52%, while revenue is expected to reach $2 billion, marking an increase of 144.32% [3] Analyst Revisions - Recent changes to analyst estimates for AeroVironment indicate a dynamic business environment, with positive revisions suggesting analyst optimism regarding the company's profitability [3] Zacks Rank and Valuation - AeroVironment currently holds a Zacks Rank of 5 (Strong Sell), with the consensus EPS projection having increased by 10.37% in the past 30 days [5] - The company is trading at a Forward P/E ratio of 82.82, which is significantly higher than the industry average Forward P/E of 38.43 [6] Industry Context - The Aerospace - Defense Equipment industry, to which AeroVironment belongs, has a Zacks Industry Rank of 162, placing it in the bottom 35% of over 250 industries [6]

Company Overview - VirTra, Inc. (VTSI) closed at $6.95, down 1.97% from the previous trading session, underperforming the S&P 500, which lost 1.6% [1] - Over the past month, shares of VirTra, Inc. gained 6.94%, while the Aerospace sector and S&P 500 gained 3.87% and 2.25%, respectively [1] Upcoming Financial Results - VirTra, Inc. is set to announce its earnings on August 11, 2025, with projected earnings per share (EPS) of $0.03, indicating a 72.73% decrease from the same quarter last year [2] - The consensus estimate for revenue is $6.38 million, reflecting a 5.11% increase from the equivalent quarter last year [2] Annual Forecast - Zacks Consensus Estimates forecast annual earnings of $0.27 per share and revenue of $29.19 million, representing increases of 125% and 7.9%, respectively, compared to the previous year [3] - Recent changes to analyst estimates indicate optimism about the business and profitability [3] Valuation Metrics - VirTra, Inc. has a Forward P/E ratio of 26.26, which is in line with the industry average [6] - The Electronics - Military industry, part of the Aerospace sector, has a Zacks Industry Rank of 98, placing it in the top 40% of over 250 industries [6] Analyst Ratings - The Zacks Rank system, which ranges from 1 (Strong Buy) to 5 (Strong Sell), currently ranks VirTra, Inc. as 3 (Hold) [5] - There has been no change in the Zacks Consensus EPS estimate over the past month [5]

Company Performance - Jabil (JBL) closed at $218.56, reflecting a -2.07% change from the previous day, underperforming the S&P 500's daily loss of 1.6% [1] - Over the past month, Jabil's shares have decreased by 1.26%, while the Computer and Technology sector gained 4.45% and the S&P 500 increased by 2.25% [1] Upcoming Financial Results - Jabil's upcoming EPS is projected at $2.92, indicating a 26.96% increase compared to the same quarter last year [2] - The consensus estimate for revenue is $7.6 billion, reflecting a 9.17% rise from the equivalent quarter last year [2] Full-Year Estimates - Zacks Consensus Estimates forecast earnings of $9.39 per share and revenue of $29.15 billion for the full year, representing year-over-year changes of +10.6% and +0.93%, respectively [3] - Recent analyst estimate revisions indicate optimism about Jabil's business and profitability [3][4] Zacks Rank and Valuation - Jabil currently holds a Zacks Rank of 1 (Strong Buy), with a historical average annual return of +25% for 1 stocks since 1988 [5] - The Zacks Consensus EPS estimate has increased by 0.21% over the past month [5] - Jabil's Forward P/E ratio is 23.78, which is a premium compared to the industry average Forward P/E of 21.71 [6] Industry Context - Jabil has a PEG ratio of 1.44, matching the average PEG ratio of the Electronics - Manufacturing Services industry [7] - The Electronics - Manufacturing Services industry is part of the Computer and Technology sector and holds a Zacks Industry Rank of 9, placing it in the top 4% of over 250 industries [8]

Company Performance - Canopy Growth Corporation (CGC) stock increased by 1.94% to $1.05, outperforming the S&P 500 which fell by 1.6% [1] - Over the past month, CGC shares have decreased by 19.53%, while the Medical sector declined by 3.44% and the S&P 500 rose by 2.25% [1] Upcoming Financial Results - Canopy Growth Corporation is set to announce its earnings on August 8, 2025, with projected earnings of -$0.15 per share, reflecting a year-over-year growth of 59.46% [2] - The consensus estimate anticipates revenue of $47.91 million, indicating a 0.99% decrease from the same quarter last year [2] Full Year Estimates - For the full year, analysts expect earnings of -$0.46 per share and revenue of $198.45 million, representing changes of +84.56% and +2.66% respectively from the previous year [3] Analyst Estimates and Market Sentiment - Recent changes to analyst estimates for Canopy Growth Corporation indicate a shifting business landscape, with positive revisions suggesting analyst optimism about profitability [4] - The Zacks Rank system, which assesses estimate changes, currently ranks Canopy Growth Corporation as 5 (Strong Sell), reflecting a 5.38% decrease in the consensus EPS estimate over the last 30 days [6] Industry Context - The Medical - Products industry, which includes Canopy Growth Corporation, has a Zacks Industry Rank of 183, placing it in the bottom 26% of over 250 industries [7]